Familial cerebral amyloid disorders with prominent white matter involvement

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Familial cerebral amyloid disorders involve protein aggregate accumulation in the brain parenchyma (plaques) and vasculature (cerebral amyloid angiopathy - CAA).
• While amyloid-beta (Aβ) is common in Alzheimer's disease and CAA, rare hereditary non-Aβ cerebral amyloidoses exist.
• These disorders present with varied clinical symptoms including cognitive decline, seizures, hemorrhage, and ataxia, with distinct imaging findings like white matter changes or calcifications.

Purpose of the Study:

• To describe the clinical, imaging, and pathological features of hereditary non-Aβ cerebral amyloidosis.
• To explore the underlying disease mechanisms of these rare amyloid disorders.
• To highlight the relevance of studying these conditions in light of emerging Aβ immunotherapies.

Main Methods:

• Review and synthesis of clinical case studies.
• Analysis of neuroimaging findings (MRI, CT).
• Pathological examination of brain tissue.

Main Results:

• Hereditary non-Aβ cerebral amyloidoses exhibit diverse clinical presentations and distinct imaging characteristics.
• Specific mutations correlate with white matter abnormalities or occipital calcifications.
• These disorders provide insights into the roles of vascular and parenchymal amyloid in neurodegeneration.

Conclusions:

• Familial cerebral amyloid disorders, particularly non-Aβ types, offer valuable models for understanding neurodegeneration and vascular contributions.
• Genotype-phenotype correlations are essential for diagnosis and therapeutic development.
• Further research is critical given the advancement of amyloid-targeting therapies.